<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC10559725</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC10559725.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">10559725</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">10559725</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">37808483</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.3389/fneur.2023.1172031</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Participant characteristics.</table-caption><table-wrap-foot>SD, standard deviation; IQR, interquartile range; CV, cerebrovascular; TIA, transient ischemic attack; WMH, white matter hyperintensity; TICV, total intracranial volume.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Participant characteristics.</p></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold><italic toggle="yes">N</italic></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>26</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Mean age (SD)</td><td valign="top" align="left" rowspan="1" colspan="1">71 (9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male:Female</td><td valign="top" align="left" rowspan="1" colspan="1">18:8</td></tr><tr style="background-color:#dee1e1;color:#ffffff"><td valign="top" align="left" colspan="2" rowspan="1"><bold>Race/Ethnicity</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  White</td><td valign="top" align="left" rowspan="1" colspan="1">21 (81%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  White-Hispanic</td><td valign="top" align="left" rowspan="1" colspan="1">2 (8%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Black</td><td valign="top" align="left" rowspan="1" colspan="1">4 (15%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Asian</td><td valign="top" align="left" rowspan="1" colspan="1">1 (4%)</td></tr><tr style="background-color:#dee1e1;color:#ffffff"><td valign="top" align="left" rowspan="1" colspan="1"><bold>Mean # CV Risk Factors (IQR)</bold></td><td valign="top" align="left" rowspan="1" colspan="1">2 (1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Hyperlipidemia</td><td valign="top" align="left" rowspan="1" colspan="1">20 (76%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Hypertension</td><td valign="top" align="left" rowspan="1" colspan="1">19 (73%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Atrial fibrillation</td><td valign="top" align="left" rowspan="1" colspan="1">8 (31%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Diabetes</td><td valign="top" align="left" rowspan="1" colspan="1">6 (23%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Obstructive Sleep Apnea</td><td valign="top" align="left" rowspan="1" colspan="1">5 (19%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Tobacco use (in past 5 years)</td><td valign="top" align="left" rowspan="1" colspan="1">4 (15%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Coronary artery disease</td><td valign="top" align="left" rowspan="1" colspan="1">2 (8%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Prior stroke (%)</td><td valign="top" align="left" rowspan="1" colspan="1">25 (96%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Two or more strokes (%)</td><td valign="top" align="left" rowspan="1" colspan="1">7 (27%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">  Prior TIA (%)</td><td valign="top" align="left" rowspan="1" colspan="1">5 (19%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median months since stroke/TIA (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1">4 (2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median months study duration (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1">18 (6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median study visits (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1">4 (2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median baseline NIH stroke scale (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1">0 (1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median baseline modified rankin score</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median chronic infarct volume ml (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1">0.7 (1.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median baseline WMH volume ml/% of TICV (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1">16 (19)/1.0% (1.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median voxel-wise WMH growth ml/% of TICV (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1">2.9 (2.6)/0.22% (0.19)</td></tr></tbody></table><table-wrap-foot><p>SD, standard deviation; IQR, interquartile range; CV, cerebrovascular; TIA, transient ischemic attack; WMH, white matter hyperintensity; TICV, total intracranial volume.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Participant characteristics.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="box" rules="all"><thead><tr><th valign="top" align="left">N</th><th valign="top" align="left">26</th></tr></thead><tbody><tr><td valign="top" align="left">Mean age (SD)</td><td valign="top" align="left">71 (9)</td></tr><tr><td valign="top" align="left">Male:Female</td><td valign="top" align="left">18:8</td></tr><tr style="background-color:#dee1e1;color:#ffffff"><td valign="top" align="left" colspan="2">Race/Ethnicity</td></tr><tr><td valign="top" align="left">  White</td><td valign="top" align="left">21 (81%)</td></tr><tr><td valign="top" align="left">  White-Hispanic</td><td valign="top" align="left">2 (8%)</td></tr><tr><td valign="top" align="left">  Black</td><td valign="top" align="left">4 (15%)</td></tr><tr><td valign="top" align="left">  Asian</td><td valign="top" align="left">1 (4%)</td></tr><tr style="background-color:#dee1e1;color:#ffffff"><td valign="top" align="left">Mean # CV Risk Factors (IQR)</td><td valign="top" align="left">2 (1)</td></tr><tr><td valign="top" align="left">  Hyperlipidemia</td><td valign="top" align="left">20 (76%)</td></tr><tr><td valign="top" align="left">  Hypertension</td><td valign="top" align="left">19 (73%)</td></tr><tr><td valign="top" align="left">  Atrial fibrillation</td><td valign="top" align="left">8 (31%)</td></tr><tr><td valign="top" align="left">  Diabetes</td><td valign="top" align="left">6 (23%)</td></tr><tr><td valign="top" align="left">  Obstructive Sleep Apnea</td><td valign="top" align="left">5 (19%)</td></tr><tr><td valign="top" align="left">  Tobacco use (in past 5 years)</td><td valign="top" align="left">4 (15%)</td></tr><tr><td valign="top" align="left">  Coronary artery disease</td><td valign="top" align="left">2 (8%)</td></tr><tr><td valign="top" align="left">  Prior stroke (%)</td><td valign="top" align="left">25 (96%)</td></tr><tr><td valign="top" align="left">  Two or more strokes (%)</td><td valign="top" align="left">7 (27%)</td></tr><tr><td valign="top" align="left">  Prior TIA (%)</td><td valign="top" align="left">5 (19%)</td></tr><tr><td valign="top" align="left">Median months since stroke/TIA (IQR)</td><td valign="top" align="left">4 (2)</td></tr><tr><td valign="top" align="left">Median months study duration (IQR)</td><td valign="top" align="left">18 (6)</td></tr><tr><td valign="top" align="left">Median study visits (IQR)</td><td valign="top" align="left">4 (2)</td></tr><tr><td valign="top" align="left">Median baseline NIH stroke scale (IQR)</td><td valign="top" align="left">0 (1)</td></tr><tr><td valign="top" align="left">Median baseline modified rankin score</td><td valign="top" align="left">1 (1)</td></tr><tr><td valign="top" align="left">Median chronic infarct volume ml (IQR)</td><td valign="top" align="left">0.7 (1.8)</td></tr><tr><td valign="top" align="left">Median baseline WMH volume ml/% of TICV (IQR)</td><td valign="top" align="left">16 (19)/1.0% (1.2)</td></tr><tr><td valign="top" align="left">Median voxel-wise WMH growth ml/% of TICV (IQR)</td><td valign="top" align="left">2.9 (2.6)/0.22% (0.19)</td></tr></tbody></table></div>SD, standard deviation; IQR, interquartile range; CV, cerebrovascular; TIA, transient ischemic attack; WMH, white matter hyperintensity; TICV, total intracranial volume.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>Baseline and longitudinal change in white matter measures.</table-caption><table-wrap-foot>aAll groups differ with p &lt;0.001, rmANOVA. bAll groups differ with p &lt;0.01, rmANOVA. cAll groups differ with p &lt;0.001 except penumbra: No Growth vs. NAWM, rmANOVA. dMixed effects linear regression was used to estimate mean annual change as a tissue × time interaction, with NAWM as the reference tissue group. *p &lt;0.05. **p &lt;0.01. ***p &lt;0.001. CI, 95% confidence interval; WMH, white matter hyperintensity; NAWM, normal appearing white matter; FW, free water; FATissue, fractional anisotropy corrected for FW; MDTissue, mean diffusivity corrected for FW; FLAIR, fluid attenuated inversion recovery MRI; rmANOVA, repeated-measures ANOVA.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>Baseline and longitudinal change in white matter measures.</p></caption><table frame="box" rules="all"><thead><tr style="background-color:#919498;color:#ffffff"><th valign="top" align="left" rowspan="1" colspan="1"><bold>Baseline mean [CI]</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Baseline WMH</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>New WMH growth</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Penumbra: no growth</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>NAWM</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">FW<sup>a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">0.520 [0.506–0.533]</td><td valign="top" align="left" rowspan="1" colspan="1">0.379 [0.369–0.389]</td><td valign="top" align="left" rowspan="1" colspan="1">0.285 [0.279–0.292]</td><td valign="top" align="left" rowspan="1" colspan="1">0.205 [0.200–0.210]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><inline-formula><mml:math id="M1" overflow="scroll"><mml:msubsup><mml:mrow><mml:mtext>FA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Tissue</mml:mtext></mml:mrow><mml:mrow><mml:mtext>b</mml:mtext></mml:mrow></mml:msubsup></mml:math></inline-formula></td><td valign="top" align="left" rowspan="1" colspan="1">0.385 [0.375–0.395]</td><td valign="top" align="left" rowspan="1" colspan="1">0.499 [0.494–0.504]</td><td valign="top" align="left" rowspan="1" colspan="1">0.556 [0.550–0.563]</td><td valign="top" align="left" rowspan="1" colspan="1">0.479 [0.475–0.483]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MD<sub>Tissue</sub> (mm<sup>2</sup>/s)<sup>a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">6.91 × 10<sup>−4</sup> [6.85–6.97]</td><td valign="top" align="left" rowspan="1" colspan="1">6.62 × 10<sup>−4</sup> [6.58–6.66]</td><td valign="top" align="left" rowspan="1" colspan="1">6.30 × 10<sup>−4</sup> [6.28–6.32]</td><td valign="top" align="left" rowspan="1" colspan="1">6.06 × 10<sup>−4</sup> [6.05–6.06]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normalized FLAIR<sup>c</sup></td><td valign="top" align="left" rowspan="1" colspan="1">1.189 [1.165–1.213]</td><td valign="top" align="left" rowspan="1" colspan="1">1.112 [1.096–1.127]</td><td valign="top" align="left" rowspan="1" colspan="1">0.977 [0.969–0.985]</td><td valign="top" align="left" rowspan="1" colspan="1">0.928 [0.920–0.937]</td></tr><tr style="background-color:#919498;color:#ffffff"><td valign="top" align="left" rowspan="1" colspan="1"><bold>Mean annual change</bold><sup>d</sup><bold>[CI]</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Baseline WMH vs. NAWM</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>New WMH growth vs. NAWM</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Penumbra: no growth vs. NAWM</bold></td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FW</td><td valign="top" align="left" rowspan="1" colspan="1">0.022<sup>*</sup> [0.005 to 0.040]</td><td valign="top" align="left" rowspan="1" colspan="1">0.034<sup>***</sup> [0.017 to 0.051]</td><td valign="top" align="left" rowspan="1" colspan="1">0.009 [−0.008 to 0.026]</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FA<sub>Tissue</sub></td><td valign="top" align="left" rowspan="1" colspan="1">−0.018<sup>*</sup> [−0.034 to −0.002]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.013 [−0.029 to 0.003]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.0009 [−0.017 to 0.015]</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MD<sub>Tissue</sub> (mm<sup>2</sup>/s)</td><td valign="top" align="left" rowspan="1" colspan="1">0.14 × 10<sup>−5</sup> [−0.7 to 1.0 × 10<sup>−5</sup>]</td><td valign="top" align="left" rowspan="1" colspan="1">1.1 × 10<sup>−5**</sup> [0.5 to 2.1 × 10<sup>−5</sup>]</td><td valign="top" align="left" rowspan="1" colspan="1">0.32 × 10<sup>−5</sup> [−0.50 to 1.1 × 10<sup>−5</sup>]</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normalized FLAIR</td><td valign="top" align="left" rowspan="1" colspan="1">−0.024 [−0.056 to 0.009]</td><td valign="top" align="left" rowspan="1" colspan="1">0.058<sup>**</sup> [0.026 to 0.090]</td><td valign="top" align="left" rowspan="1" colspan="1">0.008 [−0.024 to 0.040]</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><sup>a</sup>All groups differ with p &lt;0.001, rmANOVA. <sup>b</sup>All groups differ with p &lt;0.01, rmANOVA. <sup>c</sup>All groups differ with p &lt;0.001 except penumbra: No Growth vs. NAWM, rmANOVA. <sup>d</sup>Mixed effects linear regression was used to estimate mean annual change as a tissue × time interaction, with NAWM as the reference tissue group. <sup>*</sup>p &lt;0.05. <sup>**</sup>p &lt;0.01. <sup>***</sup>p &lt;0.001. CI, 95% confidence interval; WMH, white matter hyperintensity; NAWM, normal appearing white matter; FW, free water; FA<sub>Tissue</sub>, fractional anisotropy corrected for FW; MD<sub>Tissue</sub>, mean diffusivity corrected for FW; FLAIR, fluid attenuated inversion recovery MRI; rmANOVA, repeated-measures ANOVA.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Baseline and longitudinal change in white matter measures.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="box" rules="all"><thead><tr style="background-color:#919498;color:#ffffff"><th valign="top" align="left">Baseline mean [CI]</th><th valign="top" align="left">Baseline WMH</th><th valign="top" align="left">New WMH growth</th><th valign="top" align="left">Penumbra: no growth</th><th valign="top" align="left">NAWM</th></tr></thead><tbody><tr><td valign="top" align="left">FWa</td><td valign="top" align="left">0.520 [0.506–0.533]</td><td valign="top" align="left">0.379 [0.369–0.389]</td><td valign="top" align="left">0.285 [0.279–0.292]</td><td valign="top" align="left">0.205 [0.200–0.210]</td></tr><tr><td valign="top" align="left"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1" overflow="scroll"><mml:msubsup><mml:mrow><mml:mtext>FA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Tissue</mml:mtext></mml:mrow><mml:mrow><mml:mtext>b</mml:mtext></mml:mrow></mml:msubsup></mml:math></td><td valign="top" align="left">0.385 [0.375–0.395]</td><td valign="top" align="left">0.499 [0.494–0.504]</td><td valign="top" align="left">0.556 [0.550–0.563]</td><td valign="top" align="left">0.479 [0.475–0.483]</td></tr><tr><td valign="top" align="left">MDTissue (mm2/s)a</td><td valign="top" align="left">6.91 × 10−4 [6.85–6.97]</td><td valign="top" align="left">6.62 × 10−4 [6.58–6.66]</td><td valign="top" align="left">6.30 × 10−4 [6.28–6.32]</td><td valign="top" align="left">6.06 × 10−4 [6.05–6.06]</td></tr><tr><td valign="top" align="left">Normalized FLAIRc</td><td valign="top" align="left">1.189 [1.165–1.213]</td><td valign="top" align="left">1.112 [1.096–1.127]</td><td valign="top" align="left">0.977 [0.969–0.985]</td><td valign="top" align="left">0.928 [0.920–0.937]</td></tr><tr style="background-color:#919498;color:#ffffff"><td valign="top" align="left">Mean annual changed[CI]</td><td valign="top" align="left">Baseline WMH vs. NAWM</td><td valign="top" align="left">New WMH growth vs. NAWM</td><td valign="top" align="left">Penumbra: no growth vs. NAWM</td><td/></tr><tr><td valign="top" align="left">FW</td><td valign="top" align="left">0.022* [0.005 to 0.040]</td><td valign="top" align="left">0.034*** [0.017 to 0.051]</td><td valign="top" align="left">0.009 [−0.008 to 0.026]</td><td/></tr><tr><td valign="top" align="left">FATissue</td><td valign="top" align="left">−0.018* [−0.034 to −0.002]</td><td valign="top" align="left">−0.013 [−0.029 to 0.003]</td><td valign="top" align="left">−0.0009 [−0.017 to 0.015]</td><td/></tr><tr><td valign="top" align="left">MDTissue (mm2/s)</td><td valign="top" align="left">0.14 × 10−5 [−0.7 to 1.0 × 10−5]</td><td valign="top" align="left">1.1 × 10−5** [0.5 to 2.1 × 10−5]</td><td valign="top" align="left">0.32 × 10−5 [−0.50 to 1.1 × 10−5]</td><td/></tr><tr><td valign="top" align="left">Normalized FLAIR</td><td valign="top" align="left">−0.024 [−0.056 to 0.009]</td><td valign="top" align="left">0.058** [0.026 to 0.090]</td><td valign="top" align="left">0.008 [−0.024 to 0.040]</td><td/></tr></tbody></table></div>aAll groups differ with p &lt;0.001, rmANOVA. bAll groups differ with p &lt;0.01, rmANOVA. cAll groups differ with p &lt;0.001 except penumbra: No Growth vs. NAWM, rmANOVA. dMixed effects linear regression was used to estimate mean annual change as a tissue × time interaction, with NAWM as the reference tissue group. *p &lt;0.05. **p &lt;0.01. ***p &lt;0.001. CI, 95% confidence interval; WMH, white matter hyperintensity; NAWM, normal appearing white matter; FW, free water; FATissue, fractional anisotropy corrected for FW; MDTissue, mean diffusivity corrected for FW; FLAIR, fluid attenuated inversion recovery MRI; rmANOVA, repeated-measures ANOVA.</transformed-table></extracted-table></extracted-tables-set>